The World Federation of Societies of Biological Psychiatry guidelines on the assessment and pharmacological treatment of compulsive sexual behaviour disorder

D Turner, P Briken, J Grubbs, L Malandain… - Dialogues in Clinical …, 2022 - Taylor & Francis
Objectives The current guidelines aim to evaluate the role of pharmacological agents in the
treatment of patients with compulsive sexual behaviour disorder (CSBD). They are intended …

[HTML][HTML] Oxidative stress and neuroinflammation as a pivot in drug abuse. A focus on the therapeutic potential of antioxidant and anti-inflammatory agents and …

P Berríos-Cárcamo, M Quezada, ME Quintanilla… - Antioxidants, 2020 - mdpi.com
Drug abuse is a major global health and economic problem. However, there are no
pharmacological treatments to effectively reduce the compulsive use of most drugs of abuse …

Bupropion and naltrexone in methamphetamine use disorder

MH Trivedi, R Walker, W Ling… - … England Journal of …, 2021 - Mass Medical Soc
Background The use of naltrexone plus bupropion to treat methamphetamine use disorder
has not been well studied. Methods We conducted this multisite, double-blind, two-stage …

Association of pharmacological treatments and hospitalization and death in individuals with amphetamine use disorders in a Swedish nationwide cohort of 13 965 …

M Hartikainen, H Taipale, A Tanskanen… - JAMA …, 2023 - jamanetwork.com
Importance There are no medications approved by authorities for the treatment of
amphetamine or methamphetamine dependence, and studies investigating the …

Pharmacotherapeutic strategies for treating cocaine use disorder—what do we have to offer?

L Brandt, T Chao, SD Comer, FR Levin - Addiction, 2021 - Wiley Online Library
Background Cocaine use contines to be a significant public health problem world‐wide.
However, despite substantial research efforts, no pharmacotherapies are approved for the …

Pharmacological treatment for methamphetamine withdrawal: A systematic review and meta‐analysis of randomised controlled trials

LS Acheson, BH Williams, M Farrell… - Drug and Alcohol …, 2023 - Wiley Online Library
Issues Cessation of methamphetamine use may result in a characteristic withdrawal
syndrome, no medication has been approved for this indication. This systematic review aims …

Prescription psychostimulants for the treatment of amphetamine‐type stimulant use disorder: A systematic review and meta‐analysis of randomized placebo …

H Sharafi, H Bakouni, C McAnulty, S Drouin… - …, 2024 - Wiley Online Library
Abstract Background and Aims There is currently no standard of care for pharmacological
treatment of amphetamine‐type stimulant (ATS) use disorder (ATSUD). This systematic …

[HTML][HTML] Goofballing of opioid and methamphetamine: The science behind the deadly cocktail

HM Hazani, I Naina Mohamed, M Muzaimi… - Frontiers in …, 2022 - frontiersin.org
Globally, millions of people suffer from various substance use disorders (SUD), including
mono-and polydrug use of opioids and methamphetamine. Brain regions such as the …

Access to medications for opioid use disorder and associated factors among adolescents and young adults: a systematic review

A Pilarinos, DJ Bromberg, M Karamouzian - JAMA pediatrics, 2022 - jamanetwork.com
Importance The ongoing overdose crisis continues to adversely affect adolescents and
young adults (AYAs) and has led to numerous preventable deaths. Medications for opioid …

The past, present, and future of PrEP implementation among people who use drugs

KB Biello, MJ Mimiaga, PK Valente, N Saxena… - Current HIV/AIDS …, 2021 - Springer
Purpose of review Recent HIV outbreaks among people who use drugs (PWUD) necessitate
additional HIV prevention tools. Pre-exposure prophylaxis (PrEP) is highly efficacious yet …